BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26774019)

  • 21. [Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors].
    Ampudia-Blasco FJ; Ceriello A
    Med Clin (Barc); 2010 Sep; 135 Suppl 2():33-9. PubMed ID: 21420536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prandial glucose regulation in the glucose triad: emerging evidence and insights.
    Beisswenger P; Heine RJ; Leiter LA; Moses A; Tuomilehto J
    Endocrine; 2004 Dec; 25(3):195-202. PubMed ID: 15758245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic Index (GI) or Glycemic Load (GL) and Dietary Interventions for Optimizing Postprandial Hyperglycemia in Patients with T2 Diabetes: A Review.
    Vlachos D; Malisova S; Lindberg FA; Karaniki G
    Nutrients; 2020 May; 12(6):. PubMed ID: 32471238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
    Dworacka M; Winiarska H; Szymanska M; Kuczynski S; Szczawinska K; Wierusz-Wysocka B
    Int J Clin Pract Suppl; 2002 Jul; (129):40-4. PubMed ID: 12166605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
    Paul SK; Holman RR
    Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1
    Ma J; He H; Yang X; Chen D; Tan C; Zhong L; Du Q; Wu X; Gao Y; Liu G; Wang C; Ran X
    Nutr Diabetes; 2021 Jun; 11(1):14. PubMed ID: 34088897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific effect of postprandial glycemic peaks on HBA1c and angiopathy].
    Avignon A; Monnier L
    Diabetes Metab; 2000 Jun; 26 Suppl 2():12-5. PubMed ID: 10975044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
    Madsbad S
    J Diabetes Complications; 2016 Mar; 30(2):374-85. PubMed ID: 26541075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.
    Peter R; Okoseime OE; Rees A; Owens DR
    Curr Vasc Pharmacol; 2009 Jan; 7(1):68-74. PubMed ID: 19149642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genesis and consequences of postprandial hyperglycemia.
    Dostou JM; Einhorn D
    Postgrad Med; 2001 Dec; 110(6 Suppl):5-13. PubMed ID: 19667579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives.
    Monnier L; Benichou M; Charra-Ebrard S; Boegner C; Colette C
    Diabetes Metab; 2005 Apr; 31(2):101-9. PubMed ID: 15959415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting prandial hyperglycemia: how important is it and how best to do this?
    Monnier L; Colette C
    Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial hyperglycaemia and alpha-glucosidase inhibitors.
    Baron AD
    Diabetes Res Clin Pract; 1998 Jul; 40 Suppl():S51-5. PubMed ID: 9740503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current strategies for controlling postprandial hyperglycaemia.
    Kunt T
    Int J Clin Pract Suppl; 2001 Sep; (123):19-23. PubMed ID: 11594292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The significance of postprandial glycemia].
    Lehmann R
    Praxis (Bern 1994); 2001 Mar; 90(9):345-8. PubMed ID: 11268922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease.
    Heine RJ; Dekker JM
    Diabetologia; 2002 Apr; 45(4):461-75. PubMed ID: 12032622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycaemic instability is an underestimated problem in Type II diabetes.
    Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
    Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.